SEC Filings | Decibel Therapeutics, Inc.

Filing date	Form	Description	View
April 28, 2023	ARS	An annual report to security holders	0000950170-23-015495.pdf 0000950170-23-015495.rtf View HTML
April 14, 2023	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0000950170-23-012800.pdf 0000950170-23-012800.rtf 0000950170-23-012800.xls View HTML
April 6, 2023	8-K	Report of unscheduled material events or corporate event	0000950170-23-012063.pdf 0000950170-23-012063.rtf 0000950170-23-012063.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT View HTML
March 21, 2023	8-K	Report of unscheduled material events or corporate event	0001193125-23-075239.pdf 0001193125-23-075239.rtf 0001193125-23-075239.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 21, 2023	3	Initial filing by director officer or owner of more than ten percent.	0000899243-23-009280.pdf 0000899243-23-009280.rtf 0000899243-23-009280.xls View HTML
March 21, 2023	4	Statement of changes in beneficial ownership of securities	0000899243-23-009282.pdf 0000899243-23-009282.rtf 0000899243-23-009282.xls View HTML
March 17, 2023	4	Statement of changes in beneficial ownership of securities	0000899243-23-008873.pdf 0000899243-23-008873.rtf 0000899243-23-008873.xls View HTML
March 14, 2023	10-K	Annual report which provides a comprehensive overview of the company for the past year	0000950170-23-007849.pdf 0000950170-23-007849.rtf 0000950170-23-007849.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT View HTML
March 14, 2023	S-8	Securities offered to employees pursuant to employee benefit plans	0000950170-23-007881.pdf 0000950170-23-007881.rtf 0000950170-23-007881.xls View HTML
March 13, 2023	8-K	Report of unscheduled material events or corporate event	0000950170-23-007382.pdf 0000950170-23-007382.rtf 0000950170-23-007382.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Main Corporate Nav